Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA for Treatment of Idiopathic and Neurogenic Overactive Bladder: a Randomized Trial
Latest Information Update: 28 Mar 2024
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
Most Recent Events
- 29 Feb 2024 Status changed from recruiting to completed.
- 01 Jan 2023 Results (n=77) assessing the efficacy of a reduced injection technique of 5 injection sites was noninferior to the standard technique of 20 injection sites of intradetrusor onabotulinumtoxinA for treatment of overactive bladder, published in the Neurourology and Urodynamics.
- 18 Jul 2019 New trial record